Dupilumab Steadily Reduces IgE Levels of Patients With Atopic Dermatitis, Study Says
Investigators found a steady reduction of immunoglobulin E (IgE) levels in patients regardless of dupilumab dosing interval.
Atopic Dermatitis, Systemic Inflammation Not Linked to Dementia Risk
According to researchers, only 3 studies have previously explored a potential link between AD and dementia with inconsistent findings.
Digital Health Interventions May Improve Efficacy, Efficiency of Care in Dermatology
Researchers conducted systematic mapping of relevant digital health intervention literature to determine the impact of these interventions on dermatologic care outcomes.
Increasing Awareness of Gender-Diverse Patient Concerns in Dermatology
Matthew Mansh, MD, FAAD, discusses inequities faced by transgender and gender-diverse patient populations.
Scientists Identify Treatment Option for Rare Pansclerotic Morphea
Scientists have found a new therapy for the severe inflammatory skin disorder.
European Commission Approves Secukinumab for Hidradenitis Suppurativa
The approval makes the drug Europe’s first and only interleukin (IL)-17A inhibitor approved for the condition.
2 Clarke Drive Cranbury, NJ 08512